Brainsway (BWAY) Non-Current Deffered Revenue (2018 - 2024)
Brainsway (BWAY) posted quarterly Non-Current Deffered Revenue of $8.5 million for Q4 2024, up 52.51% year-on-year from $5.6 million in Q1 2024, and down 6.3% on a QoQ basis from $9.0 million in Q3 2024.
Brainsway (BWAY) Non-Current Deffered Revenue (2018 - 2024) Analysis & Trends
Brainsway (BWAY) has reported Non-Current Deffered Revenue for 7 consecutive years, with $8.5 million the latest figure, recorded in Q4 2024.
- Quarterly Non-Current Deffered Revenue rose 52.51% year-over-year to $8.5 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $8.5 million (up 52.51% YoY) and the FY2024 annual result came in at $8.5 million, up 52.51% from the prior year.
- Non-Current Deffered Revenue declined to $8.5 million in Q4 2024 per BWAY's latest filing, from $9.0 million in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for BWAY reached as high as $9.0 million in Q3 2024 and fell as low as $2.0 million in Q2 2020.
- A 5-year average of $4.5 million and a median of $4.6 million in 2023 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2020 — Non-Current Deffered Revenue fell 16.1% — and 2024, when it jumped 83.59%.
- Year by year, Non-Current Deffered Revenue stood at $2.1 million in 2020, then surged by 66.54% to $3.4 million in 2021, then soared by 43.99% to $4.9 million in 2022, then rose by 12.8% to $5.6 million in 2023, then surged by 52.51% to $8.5 million in 2024.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $8.5 million, $9.0 million, and $4.4 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 8.47 Mn |
| Sep 30, 2024 | 9.04 Mn |
| Jun 30, 2024 | 4.37 Mn |
| Mar 31, 2024 | 4.48 Mn |
| Dec 31, 2023 | 5.55 Mn |
| Sep 30, 2023 | 4.92 Mn |
| Jun 30, 2023 | 4.86 Mn |
| Mar 31, 2023 | 4.77 Mn |
| Dec 31, 2022 | 4.92 Mn |
| Dec 31, 2021 | 3.42 Mn |
| Dec 31, 2020 | 2.05 Mn |
| Sep 30, 2020 | 2.18 Mn |
| Jun 30, 2020 | 1.96 Mn |
| Mar 31, 2020 | 2.15 Mn |
| Dec 31, 2019 | 2.35 Mn |
| Sep 30, 2019 | 2.43 Mn |
| Jun 30, 2019 | 2.34 Mn |
| Mar 31, 2019 | 2.49 Mn |
| Dec 31, 2018 | 1.11 Mn |
| Sep 30, 2018 | 327,000.00 |